Comerica Bank’s Precigen PGEN Stock Holding History

Comerica Bank’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$268	Sell	64 -10	-14%	-$39	﹤0.01%	3662
2025 Q3	$243	Buy	+74	New	+$209	﹤0.01%	3670

Other funds holding PGEN

PCM

Patient Capital Management Baltimore, Maryland $2.74B AUM 43.59% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Comerica Bank's PGEN Position: Q4 2025 in Review

Comerica Bank reduced its Precigen (PGEN) stake by 14% in Q4 2025, selling an estimated $39 and leaving 64 shares worth $268. The position accounts for ﹤0.01% of the portfolio, ranked #3662.

Comerica Bank first reported a position in PGEN in Q3 2025 and has held it in 2 quarters since. 178 funds tracked by Wall St. Rank hold PGEN as of Q4 2025.

Comerica Bank held 64 shares of Precigen worth $268 as of Q4 2025.
Comerica Bank sold 10 Precigen shares in Q4 2025, an estimated $39.
Precigen made up ﹤0.01% of Comerica Bank's portfolio in Q4 2025, its #3662 holding.
Comerica Bank first reported a position in Precigen in Q3 2025 and has held it in 2 quarters since.
178 funds tracked by Wall St. Rank held Precigen as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.